Barely Significant

Excerpts

5,102 sentences · 1 filter applied

Discussion In this real-world study, we investigated the long-term trajectory of systemic inflammatory indices in patients with moderate-to-severe plaque psoriasis treated with guselkumab over a period of up to 156 weeks, observing an overall trend toward reduction in several markers—particularly PLR, MLR, and SIRI—supporting the hypothesis that IL-23 inhibition exerts sustained systemic anti-inflammatory effects.
The rate of grade ≥ 2 febrile neutropenia was higher among HomoMut patients and, although no statistically significant differences were observed in the other AEs analyzed, there was a clear trend toward a greater toxicity in the HomoMut group, particularly in terms of grade ≥ 2 diarrhea and anemia.